Angela Mastronuzzi: Novel insights into the immunological status of pediatric brain tumor patients
Angela Mastronuzzi, Pediatric Hematologist-Oncologist and the Head of Neuro-Oncology Unit at Bambino Gesù Children’s Hospital, shared a post on LinkedIn:
“‘Pediatric brain tumor patients display altered immune activation and reduced lymphopoiesis at the onset of disease’
Published by npj precision oncology of Nature Portfolio in collaboration with The Hormel Institute, University of Minnesota.
Our data demonstrate that glioma patients have reduced lymphopoiesis at the disease onset, which could contribute to the systemic lymphopenia characterizing these patients. This study offers novel insights into the immunological status of brain tumor patients, which may help in designing more effective treatments.
Special thank you to ‘Il Coraggio dei Bambini’ Foundation and AIRC Foundation for Cancer Research in Italy.”
Authors: Marco Rosichini, Giada Del Baldo, Carmen Dolores De Luca, Francesca Benini, Shirley Genah, Maria Vinci, Alfredo Cerimele, Marianna Coccetti, Sara Flamini, Rita Carsetti, Antonella Cacchione, Andrea Carai, Angela Mastronuzzi, Franco Locatelli, Enrico Velardi
More posts featuring Angela Mastronuzzi
Angela Mastronuzzi is pediatric hematologist-oncologist and the Head of Neuro-Oncology Unit at Bambino Gesù Children’s Hospital (Italy). She is also a professor at the UniCamillus International Medical University, and a Board Member of AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica). Her main fields of interest are CNS tumors and innovative therapies. Angela will serve as President of AIEOP starting December 1st, 2024.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023